FREE Account Opening + No Clearing Fees
Loading...

Concord Biotech IPO vs Pyramid Technoplast IPO

Comparision between Concord Biotech IPO and Pyramid Technoplast IPO.

IPO Details

Concord Biotech IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Pyramid Technoplast IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Concord Biotech IPO is up to ₹1,551.00 Cr whereas the issue size of the Pyramid Technoplast IPO is up to ₹153.05 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of Pyramid Technoplast IPO is ₹166.00 per share.

  Concord Biotech IPO Pyramid Technoplast IPO
Face Value ₹1 per share ₹10 per share
Issue Price (Lower) ₹705.00 per share ₹151.00 per share
Issue Price (Upper) ₹741.00 per share ₹166.00 per share
Issue Price (Final) ₹741.00 per share ₹166.00 per share
Discount (Retail)
Discount (Employee) ₹70.00 per share
Market Lot Size 20 shares 90 shares
Fresh Issue Size 55,00,000 shares
Fresh Issue Size (Amount) up to ₹91.30 Cr
OFS Issue Size 2,09,25,652 shares 37,20,000 shares
OFS Issue Size (Amount) up to ₹1,551.00 Cr up to ₹61.75 Cr
Issue Size Total 2,09,25,652 shares 92,20,000 shares
Issue Size Total (Amount) up to ₹1,551.00 Cr up to ₹153.05 Cr

IPO Timetable

Concord Biotech IPO opens on Aug 04, 2023, while Pyramid Technoplast IPO opens on Aug 18, 2023. The closing date of Concord Biotech IPO and Pyramid Technoplast IPO is Aug 08, 2023, and Aug 22, 2023, respectively.

  Concord Biotech IPO Pyramid Technoplast IPO
Anchor Bid Date Aug 03, 2023 Aug 17, 2023
Issue Open Aug 04, 2023 Aug 18, 2023
Issue Close Aug 08, 2023 Aug 22, 2023
Basis Of Allotment (Tentative) Aug 11, 2023 Aug 25, 2023
Initiation of Refunds (Tentative) Aug 14, 2023 Aug 28, 2023
Credit of Share (Tentative) Aug 17, 2023 Aug 29, 2023
Listing date (Tentative) Aug 18, 2023 Aug 29, 2023
Anchor Lockin End date 1 Sep 10, 2023 Sep 24, 2023
Anchor Lockin End date 2 Nov 09, 2023 Nov 23, 2023

Financials

Concord Biotech IPO P/E ratio is 32.29, as compared to Pyramid Technoplast IPO P/E ratio of 16.21.

  Concord Biotech IPO Pyramid Technoplast IPO
Financial
Concord Biotech IPO Financial Information (Restated Consolidated)
Period Ended31 Mar 202131 Mar 202231 Mar 2023
Assets1,182.551,312.801,513.98
Revenue630.75736.35888.48
Profit After Tax234.89174.93240.08
Net Worth999.371,103.221,290.00
Reserves and Surplus
Total Borrowing86.3560.5931.24
Amount in ₹ Crore
Pyramid Technoplast IPO Financial Information (Restated)
Period Ended31 Mar 202131 Mar 202231 Mar 2023
Assets153.46183.76225.78
Revenue316.18402.64482.03
Profit After Tax16.9926.1531.76
Net Worth48.8575.20107.25
Reserves and Surplus44.9471.2975.97
Total Borrowing51.3064.7755.34
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 44.08% 100.00%
Promoter Shareholding (Post-Issue) 44.08% 74.94%
P/E Ratio 32.29 16.21
Market Cap ₹7752.06 Cr. ₹611.00 Cr.
ROE 20.06%% 29.61%%
ROCE 24.27%% 21.37%%
Debt/Equity
EPS ₹20.79 ₹10.24
RoNW 20%% 29.61%%

Shares Offered

In the Concord Biotech IPO retail investors (RII) are offered 73,20,479 shares while in Pyramid Technoplast IPO retail investors are offered 73,20,479 shares. Qualified institutional buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 11,06,400 shares in Pyramid Technoplast IPO.

  Concord Biotech IPO Pyramid Technoplast IPO
Anchor Investor Reserveration 62,74,695 shares 16,59,600 shares
Market Maker Reserveration
QIB 41,83,130 shares 11,06,400 shares
NII 31,37,348 shares 18,44,000 shares
RII 73,20,479 shares 46,10,000 shares
Employee 10,000 shares 0 shares
Others
Total 1,46,50,957 shares 75,60,400 shares

Bids Received (Subscription)

Concord Biotech IPO subscribed 24.87x in total, whereas Pyramid Technoplast IPO subscribed 18.29x.

  Concord Biotech IPO Pyramid Technoplast IPO
QIB (times) 67.67x 9.94x
NII (times) 16.99x 32.24x
Big NII (times) 19.30x 33.81x
Small NII (times) 12.37x 29.09x
RII (times) 3.78x 14.72x
Employee (times) 24.48x
Other (times)
Total (times) 24.87x 18.29x

Comments

Add a public comment...